• Mashup Score: 0
    Survival in Patients With Hematologic Cancers and COVID-19 - 6 month(s) ago

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/AI96OygInS

  • Mashup Score: 5
    COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients - 8 month(s) ago

    This systematic review and meta-analysis assesses reports of clinical experiences of patients with COVID-19 and immunosuppression who were treated with specific neutralizing antibodies via COVID-19 convalescent plasma transfusion.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [Jan 12, 2023] @jwsenefeld et al. @ACasadevall1 @DrMJoyner @JAMANetworkOpen https://t.co/MozmCs6oaS #COVID19CP #COVID19 https://t.co/M6yd11ObzS

  • Mashup Score: 1
    Survival in Patients With Hematologic Cancers and COVID-19 - 8 month(s) ago

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/QJjqtd6M2Z

  • Mashup Score: 0
    COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients - 8 month(s) ago

    This systematic review and meta-analysis assesses reports of clinical experiences of patients with COVID-19 and immunosuppression who were treated with specific neutralizing antibodies via COVID-19 convalescent plasma transfusion.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [Jan 12, 2023] @jwsenefeld et al. @ACasadevall1 @DrMJoyner @JAMANetworkOpen https://t.co/MozmCs6oaS #COVID19CP #COVID19

  • Mashup Score: 1
    Survival in Patients With Hematologic Cancers and COVID-19 - 8 month(s) ago

    This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/vrVrF5D0i8

Load More